User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Concentration of transfusion resources on a few pathologies and a few patients: analysis of the comprehensive in-hospital patient database.

Primary tabs

Beguin, Claire Closon, Marie-Christine [UCL] Vandekerckhove, Philippe Baele, Philippe [UCL]

BACKGROUND: Blood is a sparse commodity. Transfusion needs increase while the number of donors decreases. These constraints incite Belgian authorities to pay more attention to transfusion financing. This implies pathologic knowledge of the epidemiology of in-hospital transfusion and the consumption of blood products. STUDY DESIGN AND METHODS: This study is a retrospective analysis of in-hospital stays from the year 2000 and includes data from all 124 Belgian hospitals. The database contains information on diagnoses, procedures, and all-patients refined diagnosis-related groups (APRDRGs) but also on expenses linked to blood products transfused and to transfusion-related pharmaceutical products. RESULTS: Three percent of surgical patients used 55.7 percent of transfusion resources and 75.4 percent of transfusion costs were associated with 24 APRDRGs. In the medical group, 3 percent of the patients accounted for 80.2 percent of transfusion costs and 20 APRDRGs consumed 71.9 percent of transfusion resources. The variables with the highest impact on the proportion of patients transfused were severity, pathology, and age. The effect of hospitals remained significant but had less impact. No substitution of blood products by transfusion-related pharmaceutical products was observed in our analysis. CONCLUSION: Our study confirms that transfusion now centers on a limited number of pathologic entities and, within those, in small subsets of patients. This implies that the costs linked to setting up and running the transfusion system can no longer be shared by a large number of patients who receive transfusions but rely increasingly on patients at higher risks of more unpredictable needs. The system must nevertheless be able to cope with them at any time.

  1. Closon MC, Etude d'une methode de financement alternative pour le sang et les derives sanguins labiles dans les hopitaux [monograph on the Internet]. (2005)
  2. Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, McGurk S, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD, The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals, 10.1046/j.1537-2995.1998.38298193094.x
  3. HASLEY PEGGY B., LAVE JUDITH R., HANUSA BARBARA H., ARENA VINCENT C., RAMSEY GLENN, KAPOOR WISHWA N., FINE MICHAEL J., Variation in the Use of Red Blood Cell Transfusions; A Study of Four Common Medical and Surgical Conditions : , 10.1097/00005650-199511000-00007
  4. Reyal Fabien, Sibony Olivier, Oury Jean-François, Luton Dominique, Bang Jacques, Blot Philippe, Criteria for transfusion in severe postpartum hemorrhage: analysis of practice and risk factors, 10.1016/j.ejogrb.2003.04.001
  5. Jansen A J. G., van Rhenen D J., Steegers E A. P., Duvekot J J., Postpartum Hemorrhage and Transfusion of Blood and Blood Components : , 10.1097/01.ogx.0000180909.31293.cf
  6. Dash Atreya, Dunn Rodney L, Resh Jennifer, Wei John T, Montie James E, Sanda Martin G, Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling, 10.1016/j.urology.2004.02.018
  7. Seshadri T, Med J Aust, 182, 453 (2005)
  8. Surgenor DM, Wallace EL, Churchill WH, Hao SH, Chapman RH, Poss R, Red cell transfusions in total knee and total hip replacement surgery, 10.1046/j.1537-2995.1991.31691306252.x
  9. Surgenor DM, Wallace EL, Churchill WH, Hao SH, Chapman RH, Collins JJ, Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107), 10.1046/j.1537-2995.1992.32592327721.x
  10. Syrjala M. T., Kytoniemi I., Mikkolainen K., Ranimo J., Lauharanta J., Transfusion practice in Helsinki University Central Hospital: an analysis of diagnosis-related groups (DRG), 10.1046/j.1365-3148.2001.00338.x
  11. Jefferies Leigh C., Sachais Bruce S., Young Donald S., Blood transfusion costs by diagnosis-related groupsin 60 university hospitals in 1995, 10.1046/j.1537-2995.2001.41040522.x
  12. Use of blood products for elective surgery in 43 European hospitals, Transfus Med, 4, 251 (1994)
  13. Brien WF, CMAJ, 140, 812 (1989)
  14. Ghali WA, CMAJ, 150, 1449 (1994)
  15. Titlestad K., Georgsen J., Jorgensen J., Kristensen T., Monitoring transfusion practices at two university hospitals, 10.1046/j.1423-0410.2001.00001.x
  16. Hutton B, Can J Anesth, 52, 581 (2005)
  17. Titlestad Kjell, Clinical epidemiology of transfusion medicine, 10.1016/j.transci.2004.06.006
  18. Baele P, Acta Anaesth Belg, 49, 243 (1998)
  19. Loudon B., Smith M. P., Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: a pharmacoeconomic evaluation : rFVIIa for large volume transfusion, 10.1111/j.1445-5994.2005.00878.x
  20. A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit, 10.1056/nejmoa040232
  21. Lienhart A, Bull Acad Natl Med, 188, 1429 (2004)
Bibliographic reference Beguin, Claire ; Closon, Marie-Christine ; Vandekerckhove, Philippe ; Baele, Philippe. Concentration of transfusion resources on a few pathologies and a few patients: analysis of the comprehensive in-hospital patient database.. In: Transfusion, Vol. 47, no. 2, p. 217-27 (2007)
Permanent URL http://hdl.handle.net/2078.1/22242